Meningococcal Infections - 25 Studies Found Completed : Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection : Meningococcal Infections : 2007-03-21 Active, not recruiting : Investigating the Immunogenicity of a U.S.-Licensed Meningococcal Serogroup B Vaccine (Trumenba) : Meningococcal Infections : 2015-09-30 : Biological: Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals) All subjects will receive three doses of a T Completed : Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age : Meningococcal Infection : 2006-04-03 : Biological: Meningococcal C conjugate vaccine Completed : Immunogenicity of the Booster Dose of Two MenC Vaccines : Meningococcal Infection : 2006-10-25 : Biological: conjugated polysaccharide menC vaccine Booster vaccine dose at 14 to 18 months. Completed : Safety, Tolerability and Immunogenicity of Meningococcal B Recombinant Vaccine Administered With or Without Routine Infant Vaccinations to Healthy Infants According to Different Immunization Schedules : Meningococcal Infections : 2008-07-22 : Biological: rMenB+OMV NZ Biological: combi Completed : Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers : Meningococcal Infection : 2011-04-14 : Biological: Meningococcal vaccine GSK 134612 Completed : Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers : Meningococcal Infections : 2008-02-20 : Biological: MenACWY-CRM + MMRV Completed : Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children : Meningococcal Infections : 2008-01-31 : Biological: MenACWY-CRM 1 inje Completed : A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years : MENINGOCOCCAL INFECTION : 2015-08-20 : Biological: Bivalent rLP2086 Vaccine Completed : Duration of Immunity Study : Meningococcal Infection : 2012-02-17 : Procedure: blood sampling Bloo Next >>>
